Are rising FSH and LH characteristic of the menopausal transition?

The transition into menopause is fundamentally defined by shifts in the hypothalamic-pituitary-ovarian (HPO) axis, where the depletion of ovarian follicles disrupts the homeostatic regulation of reproductive hormones.

Clinical and effectiveness evidence

The elevation of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) is a well-established biochemical hallmark of the menopausal transition. Longitudinal research, such as the Study of Women's Health Across the Nation (SWAN), has quantified these shifts:

• FSH and LH escalation: During perimenopause, FSH levels typically rise significantly—often exceeding 25–30 IU/L—while LH levels can increase by approximately 3.7 times compared to premenopausal baseline.
• Early vs. late transition: FSH typically rises earlier and more sharply than LH. This is because FSH is more sensitive to the initial drop in inhibin B, whereas LH remains under tighter feedback control from estradiol until closer to the final menstrual period.

Mechanistic explanations

The rise in gonadotropins is a direct compensatory response to the loss of ovarian negative feedback. Under normal physiological conditions, the ovaries produce estradiol and inhibins that signal the brain to limit FSH and LH production.

• Inhibin B depletion: As the antral follicle pool shrinks, production of inhibin B—the primary suppressor of FSH—drops. This allows for unopposed activin drive at the pituitary, specifically stimulating FSH synthesis.
• Estradiol feedback failure: Later in the transition, as follicular maturation fails, estradiol production becomes erratic and eventually declines. This removes the ERα-dependent negative feedback at both the hypothalamus (reducing GnRH suppression) and the pituitary, leading to sustained elevations in both FSH and LH.

Bottom line

The rise of FSH and LH is a primary diagnostic indicator of the menopausal transition. This "hypergonadotropic" state is the direct result of the ovaries losing their ability to provide negative feedback through estradiol and inhibins as the follicular reserve is exhausted.